Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni in HCV-infected Beta-Thalassemic Children
NCT03961828Phase 4Completed
- Sponsor
- Tanta University
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ledipasvir in hepatitis C (HCV), sponsored by Tanta University. Started Oct 2017; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03961828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961828.